Loading…

Frailty and cardiovascular mortality in more than 3 million US Veterans

Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality. All US...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal 2022-02, Vol.43 (8), p.818-826
Main Authors: Shrauner, William, Lord, Emily M, Nguyen, Xuan-Mai T, Song, Rebecca J, Galloway, Ashley, Gagnon, David R, Driver, Jane A, Gaziano, J Michael, Wilson, Peter W F, Djousse, Luc, Cho, Kelly, Orkaby, Ariela R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533
cites cdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533
container_end_page 826
container_issue 8
container_start_page 818
container_title European heart journal
container_volume 43
creator Shrauner, William
Lord, Emily M
Nguyen, Xuan-Mai T
Song, Rebecca J
Galloway, Ashley
Gagnon, David R
Driver, Jane A
Gaziano, J Michael
Wilson, Peter W F
Djousse, Luc
Cho, Kelly
Orkaby, Ariela R
description Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality. All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization. In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished. Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events? Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization. Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease.
doi_str_mv 10.1093/eurheartj/ehab850
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9890630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610412466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</originalsourceid><addsrcrecordid>eNpVUU1LAzEQDaJorf4AL7JHL6uTZJMmF0GKVaHgwQ-8hdls1qZkdzXZFfrvbbEWPQ3D-5jHPELOKFxS0PzKDXHhMPbLK7fAUgnYIyMqGMu1LMQ-GQHVIpdSvR2R45SWAKAklYfkiBcaJgVjI3I3i-hDv8qwrTKLsfLdFyY7BIxZ08Ueg1-Dvt0sLusX2GY8a3wIvmuzl6fs1fUuYptOyEGNIbnT7RyTl9nt8_Q-nz_ePUxv5rnlWve5EsoqS4WdgKjVBGtmQQJahU6D1VCVWNZU2WJCK0YLVtPCVkLzUkvrrOB8TK5_fD-GsnGVdW0fMZiP6BuMK9OhN_-R1i_Me_dltNIgOawNLrYGsfscXOpN45N1IWDruiEZJikUlBVSrqn0h2pjl1J09e4MBbMpwOwKMNsC1przv_l2it-P82-K1Yce</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610412466</pqid></control><display><type>article</type><title>Frailty and cardiovascular mortality in more than 3 million US Veterans</title><source>Oxford Journals Online</source><creator>Shrauner, William ; Lord, Emily M ; Nguyen, Xuan-Mai T ; Song, Rebecca J ; Galloway, Ashley ; Gagnon, David R ; Driver, Jane A ; Gaziano, J Michael ; Wilson, Peter W F ; Djousse, Luc ; Cho, Kelly ; Orkaby, Ariela R</creator><creatorcontrib>Shrauner, William ; Lord, Emily M ; Nguyen, Xuan-Mai T ; Song, Rebecca J ; Galloway, Ashley ; Gagnon, David R ; Driver, Jane A ; Gaziano, J Michael ; Wilson, Peter W F ; Djousse, Luc ; Cho, Kelly ; Orkaby, Ariela R</creatorcontrib><description>Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality. All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization. In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished. Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events? Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization. Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehab850</identifier><identifier>PMID: 34907422</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; Aged ; Cardiovascular Diseases ; Clinical Research ; Editor's Choice ; Female ; Frailty - complications ; Frailty - epidemiology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Male ; Myocardial Infarction - complications ; Myocardial Infarction - epidemiology ; Risk Factors ; Stroke - complications ; Stroke - epidemiology ; Veterans</subject><ispartof>European heart journal, 2022-02, Vol.43 (8), p.818-826</ispartof><rights>Published by Oxford University Press on behalf of the European Society of Cardiology 2021. This work is written by US Government employees and is in the public domain in the US.</rights><rights>Published by Oxford University Press on behalf of the European Society of Cardiology 2021. This work is written by US Government employees and is in the public domain in the US. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</citedby><cites>FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</cites><orcidid>0000-0001-7171-7437 ; 0000-0001-8431-1698 ; 0000-0003-3083-5386 ; 0000-0002-4297-6306 ; 0000-0001-6299-3763</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34907422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shrauner, William</creatorcontrib><creatorcontrib>Lord, Emily M</creatorcontrib><creatorcontrib>Nguyen, Xuan-Mai T</creatorcontrib><creatorcontrib>Song, Rebecca J</creatorcontrib><creatorcontrib>Galloway, Ashley</creatorcontrib><creatorcontrib>Gagnon, David R</creatorcontrib><creatorcontrib>Driver, Jane A</creatorcontrib><creatorcontrib>Gaziano, J Michael</creatorcontrib><creatorcontrib>Wilson, Peter W F</creatorcontrib><creatorcontrib>Djousse, Luc</creatorcontrib><creatorcontrib>Cho, Kelly</creatorcontrib><creatorcontrib>Orkaby, Ariela R</creatorcontrib><title>Frailty and cardiovascular mortality in more than 3 million US Veterans</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality. All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization. In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished. Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events? Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization. Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease.</description><subject>Adult</subject><subject>Aged</subject><subject>Cardiovascular Diseases</subject><subject>Clinical Research</subject><subject>Editor's Choice</subject><subject>Female</subject><subject>Frailty - complications</subject><subject>Frailty - epidemiology</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors</subject><subject>Male</subject><subject>Myocardial Infarction - complications</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Risk Factors</subject><subject>Stroke - complications</subject><subject>Stroke - epidemiology</subject><subject>Veterans</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVUU1LAzEQDaJorf4AL7JHL6uTZJMmF0GKVaHgwQ-8hdls1qZkdzXZFfrvbbEWPQ3D-5jHPELOKFxS0PzKDXHhMPbLK7fAUgnYIyMqGMu1LMQ-GQHVIpdSvR2R45SWAKAklYfkiBcaJgVjI3I3i-hDv8qwrTKLsfLdFyY7BIxZ08Ueg1-Dvt0sLusX2GY8a3wIvmuzl6fs1fUuYptOyEGNIbnT7RyTl9nt8_Q-nz_ePUxv5rnlWve5EsoqS4WdgKjVBGtmQQJahU6D1VCVWNZU2WJCK0YLVtPCVkLzUkvrrOB8TK5_fD-GsnGVdW0fMZiP6BuMK9OhN_-R1i_Me_dltNIgOawNLrYGsfscXOpN45N1IWDruiEZJikUlBVSrqn0h2pjl1J09e4MBbMpwOwKMNsC1przv_l2it-P82-K1Yce</recordid><startdate>20220222</startdate><enddate>20220222</enddate><creator>Shrauner, William</creator><creator>Lord, Emily M</creator><creator>Nguyen, Xuan-Mai T</creator><creator>Song, Rebecca J</creator><creator>Galloway, Ashley</creator><creator>Gagnon, David R</creator><creator>Driver, Jane A</creator><creator>Gaziano, J Michael</creator><creator>Wilson, Peter W F</creator><creator>Djousse, Luc</creator><creator>Cho, Kelly</creator><creator>Orkaby, Ariela R</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7171-7437</orcidid><orcidid>https://orcid.org/0000-0001-8431-1698</orcidid><orcidid>https://orcid.org/0000-0003-3083-5386</orcidid><orcidid>https://orcid.org/0000-0002-4297-6306</orcidid><orcidid>https://orcid.org/0000-0001-6299-3763</orcidid></search><sort><creationdate>20220222</creationdate><title>Frailty and cardiovascular mortality in more than 3 million US Veterans</title><author>Shrauner, William ; Lord, Emily M ; Nguyen, Xuan-Mai T ; Song, Rebecca J ; Galloway, Ashley ; Gagnon, David R ; Driver, Jane A ; Gaziano, J Michael ; Wilson, Peter W F ; Djousse, Luc ; Cho, Kelly ; Orkaby, Ariela R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cardiovascular Diseases</topic><topic>Clinical Research</topic><topic>Editor's Choice</topic><topic>Female</topic><topic>Frailty - complications</topic><topic>Frailty - epidemiology</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors</topic><topic>Male</topic><topic>Myocardial Infarction - complications</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Risk Factors</topic><topic>Stroke - complications</topic><topic>Stroke - epidemiology</topic><topic>Veterans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shrauner, William</creatorcontrib><creatorcontrib>Lord, Emily M</creatorcontrib><creatorcontrib>Nguyen, Xuan-Mai T</creatorcontrib><creatorcontrib>Song, Rebecca J</creatorcontrib><creatorcontrib>Galloway, Ashley</creatorcontrib><creatorcontrib>Gagnon, David R</creatorcontrib><creatorcontrib>Driver, Jane A</creatorcontrib><creatorcontrib>Gaziano, J Michael</creatorcontrib><creatorcontrib>Wilson, Peter W F</creatorcontrib><creatorcontrib>Djousse, Luc</creatorcontrib><creatorcontrib>Cho, Kelly</creatorcontrib><creatorcontrib>Orkaby, Ariela R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shrauner, William</au><au>Lord, Emily M</au><au>Nguyen, Xuan-Mai T</au><au>Song, Rebecca J</au><au>Galloway, Ashley</au><au>Gagnon, David R</au><au>Driver, Jane A</au><au>Gaziano, J Michael</au><au>Wilson, Peter W F</au><au>Djousse, Luc</au><au>Cho, Kelly</au><au>Orkaby, Ariela R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frailty and cardiovascular mortality in more than 3 million US Veterans</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2022-02-22</date><risdate>2022</risdate><volume>43</volume><issue>8</issue><spage>818</spage><epage>826</epage><pages>818-826</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality. All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization. In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished. Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events? Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization. Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34907422</pmid><doi>10.1093/eurheartj/ehab850</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7171-7437</orcidid><orcidid>https://orcid.org/0000-0001-8431-1698</orcidid><orcidid>https://orcid.org/0000-0003-3083-5386</orcidid><orcidid>https://orcid.org/0000-0002-4297-6306</orcidid><orcidid>https://orcid.org/0000-0001-6299-3763</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2022-02, Vol.43 (8), p.818-826
issn 0195-668X
1522-9645
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9890630
source Oxford Journals Online
subjects Adult
Aged
Cardiovascular Diseases
Clinical Research
Editor's Choice
Female
Frailty - complications
Frailty - epidemiology
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Myocardial Infarction - complications
Myocardial Infarction - epidemiology
Risk Factors
Stroke - complications
Stroke - epidemiology
Veterans
title Frailty and cardiovascular mortality in more than 3 million US Veterans
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T02%3A46%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frailty%20and%20cardiovascular%20mortality%20in%20more%20than%203%20million%20US%20Veterans&rft.jtitle=European%20heart%20journal&rft.au=Shrauner,%20William&rft.date=2022-02-22&rft.volume=43&rft.issue=8&rft.spage=818&rft.epage=826&rft.pages=818-826&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehab850&rft_dat=%3Cproquest_pubme%3E2610412466%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2610412466&rft_id=info:pmid/34907422&rfr_iscdi=true